AstraZeneca plc vs Hasbro, Inc. — how do they compare? AstraZeneca plc trades at $157.99 (market cap $248.14B), while Hasbro, Inc. trades at $97.48 (market cap $13.69B). The key difference: AstraZeneca plc is far larger — about 18.1× Hasbro, Inc.'s market cap, and Hasbro, Inc. pays the higher dividend (2.89%). Which is the better fit depends on your goals.
| AZN | HAS | |
|---|---|---|
Market Cap | $248.14B | $13.69B |
Sector | Health | Consumer Cyclical |
52-Week High | $209.48 | $105.88 |
52-Week Low | $147.06 | $70.95 |
Enterprise Value | $275.41B | $15.88B |
Dividend Yield | 2.01% | 2.89% |
Trailing returns across standard periods
Latest headlines on both assets
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →Hasbro is a branded play company providing children and families around the world with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and a licensing program, Hasbro reaches customers by leveraging its well-known brands such as Transformers, Nerf, and Magic: The Gathering. Ownership stakes in Discovery Family, which offers programming around Hasbro brands, and owned production capabilities from Entertainment One help bolster Hasbro's multichannel presence. The firm acquired Entertainment One in 2019, bolting on popular properties like Peppa Pig and PJ Masks, and has plans to tie up with Dungeons & Dragons Beyond in 2022, offering the firm access 10 million digital tabletop players.
Read more on HAS →